1. 1) Gnepp, D.R., Brandwein-Gensler, M.S., et al.: Carcinoma ex pleomorphic adenoma. Barnes, L., Eveson, J.W., et al.; World health organization classification of tumours: pathology and genetics of head and neck tumours, IARC, Lyon, 2005, 242-243.
2. 2) Pires, F.R., Pringle, G.A., et al.: Intra-oral minor salivary gland tumors: a clinicopathological study of 546 cases. Oral Oncol 43:463-470, 2007.
3. 3) Andreasen, S., Therkildsen, M.H., et al.: Pleomorphic adenoma of the parotid gland 1985-2010: A Danish nationwide study of incidence, recurrence rate, and malignant transformation. Head Neck 38:1364-1369, 2016.
4. 4) Williams, M.D., Ihrler, S., et al.: Carcinoma ex pleomorphic adenoma. EL-Naggar, A.K., Chan, J., et al.; World health organization classification of tumours: pathology and genetics of head and neck tumours, IARC, Lyon, 2017, 176-177.
5. 5) Seethala, R.R., Stenman, G.: Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Salivary Gland. Head Neck Pathol 11:55-67, 2017.